SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Maul Coin

Maul Coin is trending as the community actively coordinates to push the token's visibility on social platforms and trading sites, fueled by an active developer and hopes of reaching higher market caps. While enthusiasts celebrate its organic growth and community-driven approach, skeptics remain vocal about concerns regarding potential volatility, lack of a chart, and typical risks associated with low-cap crypto projects.

Zebec's integrated products - real time payroll apps, on-chain payments infrastructure and networked DePIN - serve companies of all sizes, merchants and individuals and help transcend the boundaries of traditional banking and diminish the role of financial intermediaries.

Zebec Network

Zebec Network is trending as community members rally around anticipation of a major upcoming partnership announcement, widely speculated to involve Ripple or XRP, alongside excitement over its new global stablecoin payroll integration with Stellar. While some investors focus on long-term utility and potential listings on major exchanges, community discourse remains polarized between optimistic holders eyeing generational wealth and skeptics dismissing recent price action as a pump-and-dump cycle.

Veil Cash is a privacy application leveraging zk-SNARKs on Base L2, enabling verified depositors to achieve privacy and anonymity within a pool of trusted users.  Veil Cash is a non-custodial privacy protocol on Base L2. Veil Cash's goal will be enabling verified users to achieve privacy and anonymity from trusted pools.  Veil is a set of smart contracts that will allow users that are deemed as verified users to deposit into the protocol. Users can later withdraw their deposits from another address without creating a link between these two addresses.   Verified users are those who meet certain criteria based on both on-chain and off-chain data.

Veil-project

VEIL is trending as community members rally behind its privacy-focused technology on the Base network, often citing support from Coinbase Ventures as a key catalyst. Enthusiasts are actively discussing the project's long-term potential for adoption and its mining and staking features, viewing it as a essential tool for digital sovereignty.

Monad is a high-performance Layer 1 blockchain that processes 10,000 transactions per second with near-zero fees. The platform delivers high performance without compromising on security or decentralization, creating the infrastructure needed for complex applications that require high-frequency activity.  One of Monad’s key innovations lies in how it handles transaction processing. Instead of processing transactions one at a time like traditional blockchains, Monad processes multiple transactions simultaneously through parallel execution.   The system separates the agreement process from the execution process, allowing validators to first agree on which transactions to include and in what order, then having more time to execute those transactions without slowing down consensus. This approach, combined with a custom-built database called MonadDB, dramatically increases throughput while maintaining accuracy.  Monad also offers complete EVM compatibility, where applications built for Ethereum work on Monad without any code modifications, and users can connect with familiar wallets like MetaMask just as they would on Ethereum. Developers can immediately tap into Ethereum's established ecosystem of tools, libraries, and applications while benefitting from Monad’s performance improvements. The platform also runs on consumer-grade hardware rather than expensive specialized equipment, making it accessible for more people to participate in securing the network.  Monad has raised approximately 244 million dollars in total funding across multiple rounds. The company secured 19 million dollars in a seed round in February 2023 led by Dragonfly Capital, followed by a 225 million dollar Series A round in April 2024 led by Paradigm at a 3 billion dollar valuation. Other notable investors include Electric Capital, Greenoaks, Coinbase Ventures, and prominent angel investors such as Naval Ravikant.

Monad

Monad is capturing significant trader attention as a high-performance Layer 1 blockchain, with the community actively debating its potential to rival existing networks through speed and parallel processing. While price action has seen volatility alongside broader crypto market trends, discussions are heavily focused on long-term accumulation, staking rewards, and anticipation of upcoming ecosystem developments.

Monero

Monero (XMR) is trending as the community debates its role as the premier privacy-focused asset, with active discussions focusing on its unique resistance to regulatory oversight compared to transparent chains. Enthusiasts view it as a long-term store of value and a hedge against institutional tracking, while detractors continue to characterize the asset through speculative or cynical lenses.

QuantumScape Corp. engages in developing next-generation solid-state lithium-metal batteries. The company’s next-generation batteries are designed to enable greater energy density, faster charging, and enhanced safety to support the transition away from legacy energy sources toward a lower-carbon future. The company was founded by Jagdeep Singh, Tim Holme, and Fritz B. Prinz in May 2010 and is headquartered in San Jose, CA.

QuantumScape Corp - Ordinary Shares - Class A

QuantumScape Corp

QuantumScape is currently facing significant downward pressure and investor frustration, with the community actively debating whether the stock is a long-term 'holy grail' opportunity or a failing venture as it sits at a critical technical support level. Investors remain highly focused on upcoming manufacturing milestones and the potential for a short squeeze, while sentiment is polarized between those accumulating shares for a multi-year horizon and others disillusioned by the lack of immediate commercial catalysts.

"What's Updog?" is a Community Led token.

UpDog

The UpDog community is rallying around the project's longevity and humorous branding, actively promoting the token's presence across major platforms and cross-promoting with other popular assets. Enthusiasts are focused on organic growth and widespread adoption, frequently engaging with the community through social memes and dedicated poker events.

Dutch Bros, Inc. engages in operating and franchising drive-thru shops that focus on handcrafted beverages. It operates through the Company-Operated Shops, and Franchising and Other segments. The Company-Operated Shops segment consists of coffee shop sales to customers. The Franchising and Other segment is involved in bean and product sales to franchisees and includes the initial franchise fees, royalties, and marketing fees. The company was founded by Travis Boersma and Dane Boersma in 1992 and is headquartered in Tempe, AZ.

Dutch Bros Inc - Ordinary Shares - Class A

Dutch Bros Inc

Dutch Bros is experiencing heightened volatility and intense social media discussion as the community debates its valuation and high price-to-earnings ratio ahead of its earnings release. While some investors remain cautious about margin pressures and the macro environment, others are highlighting strong unit-level economics, rapid store expansion, and high customer loyalty as reasons to hold the stock through the uncertainty.

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Biocryst Pharmaceuticals Inc.

Biocryst Pharmaceuticals is currently experiencing significant market movement and high volume driven by intense community speculation regarding a potential buyout or M&A activity. The stock has seen unusual after-hours trading and sustained call option accumulation, leading investors to closely monitor for official announcements or catalyst-driven price volatility.

Jupiter is a cryptocurrency exchange platform on the Solana blockchain, offering features such as token swapping, limit orders, dollar-cost averaging, and a bridge for asset transfers to Solana. It provides users with tools to find the best trading prices and includes a beta version for perpetual futures trading. Jupiter finds the best price route for your swap by aggregating all the major liquidity sources on Solana.

Jupiter

Jupiter is experiencing significant social media engagement as the community actively rallies behind the long-standing UpDog token and various emerging Solana-based projects. Users are heavily discussing the utility of Jupiter's lending and borrowing protocols, while simultaneously promoting specific meme coins and liquidity strategies across the Solana ecosystem.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Ironwood Pharmaceuticals (NASDAQ:IRWD) Trading Down 5.8% - Time to Sell?

Ironwood Pharmaceuticals (NASDAQ:IRWD) Shares Down 5.8% - Time to Sell...

Range Financial Group LLC Acquires Shares of 426,095 Ironwood Pharmaceuticals, Inc. $IRWD

Range Financial Group LLC bought a new position in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 426,095 shares of the biotechnology company's st...

Ironwood Pharmaceuticals (NASDAQ:IRWD) Stock Price Up 5.4%  - Still a Buy?

Ironwood Pharmaceuticals (NASDAQ:IRWD) Trading 5.4% Higher - Time to Buy...

IRWD Stock Down 14% in a Month: Time to Buy, Sell or Hold the Stock?

Ironwood slides 14% in a month on weak Linzess Q4 sales, but strong demand, partnerships, and an upbeat 2026 outlook raise investor optimism.

Why Is Ironwood (IRWD) Down 13.9% Since Last Earnings Report?

Ironwood (IRWD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Given Average Recommendation of "Hold" by Brokerages

Shares of Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD - Get Free Report) have been given an average recommendation of "Hold" by the eight brokerages that are currently covering the firm, Marketbeat...

Ironwood Pharmaceuticals (NASDAQ:IRWD) Stock Price Up 9% - Time to Buy?

Ironwood Pharmaceuticals (NASDAQ:IRWD) Trading 9% Higher - Should You Buy...

Alexander Denner Sells 6,730,800 Shares of Ironwood Pharmaceuticals (NASDAQ:IRWD) Stock

Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD - Get Free Report) Director Alexander Denner sold 6,730,800 shares of the business's stock in a transaction on Tuesday, March 17th. The shares were sold at...

Insider Selling: Ironwood Pharmaceuticals (NASDAQ:IRWD) Director Sells 6,730,800 Shares of Stock

Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD - Get Free Report) Director Alexander Denner sold 6,730,800 shares of the stock in a transaction that occurred on Tuesday, March 17th. The shares were sold...

Ironwood Pharmaceuticals (NASDAQ:IRWD) Sees Strong Trading Volume - Should You Buy?

Ironwood Pharmaceuticals (NASDAQ:IRWD) Sees Large Volume Increase - Should You Buy...

Ironwood Pharmaceuticals, Inc. is a healthcare company, which engages in the development and commercialization of Gastrointestinal (GI) products. It operates through the Human Therapeutics segment. The company was founded on January 5, 1998 and is headquartered in Boston, MA.

Ironwood Pharmaceuticals Inc - Ordinary Shares - Class A

Opendoor ($OPEN)

Strategy ($MSTR)

American Eagle ($AEO)

Ondas Inc. ($ONDS)

The stock that proved the power of the crowd. Fueled by community energy and social momentum, this winner captivated retail investors regardless of what the "experts" or traditional fundamentals had to say.

IRWD
Ironwood Pharmaceuticals Inc - Ordinary Shares - Class A

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest IRWD News

IRWDIronwood Pharmaceuticals Inc - Ordinary Shares - Class A